Selepressin Evaluation Programme for Sepsis-Induced Shock - Adaptive Clinical Trial

NCT02508649 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

868

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated due to futility

Conditions

Septic Shock

Interventions

DRUG: selepressin
DRUG: placebo

Sponsor

Ferring Pharmaceuticals